Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Basal Cell × Gels × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 10 Condylomata Acuminata 3 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Warts 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Urologic Neoplasms 1 Urologic Diseases 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Sexually Transmitted Diseases 1 Radiodermatitis 1 Papillomavirus Infections 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Keratosis, Seborrheic 1 Hemangioma, Cavernous 1 Hemangioma 1 Head and Neck Cancer Patients Treated With Radiotherapy 1 Exanthema 1 Dermatitis, Contact 1 Carcinoma, Basal Cell 1 Carcinoma 1

Interventions

HhAntag691 18 Imiquimod 10 sonidegib 8 Photochemotherapy 7 1-phenyl-3,3-dimethyltriazene 6 methyl 5-aminolevulinate 4 Surgical Procedures, Operative 4 Biopsy 4 Aminolevulinic Acid 4 cemiplimab 3 Mohs Surgery 3 Microscopy, Confocal 3 Itraconazole 3 IPI-926 3 3-ingenyl angelate 3 tazarotene 2 Microarray Analysis 2 Laser Therapy 2 Gene Expression Profiling 2 Eflornithine 2 Drug Evaluation 2 Acitretin 2 tozuleristide 1 teriflunomide 1 talimogene laherparepvec 1 silmitasertib 1 remetinostat 1 pembrolizumab 1 gusacitinib 1 green tea extract polyphenone E 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03546166 2023-07-21

PICABAS

Centre Hospitalier Universitaire de Nice

Phase 2 Completed

Carcinoma, Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡